Petrus Trust Company’s Teladoc Health TDOC Stock Holding History

Petrus Trust Company’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-19,060	Closed	-$166K	–	500
2025 Q2	$166K	Buy	+19,060	New	+$138K	0.02%	477

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Petrus Trust Company's TDOC Position: Q3 2025 in Review

Petrus Trust Company sold out of Teladoc Health (TDOC) in Q3 2025, closing a stake of 19,060 shares — an estimated $166K sold.

Petrus Trust Company first reported a position in TDOC in Q2 2025 and held it in 1 quarter. The position peaked at $166K in Q2 2025. 355 funds tracked by Wall St. Rank hold TDOC as of Q3 2025.

Petrus Trust Company reported no remaining Teladoc Health position as of Q3 2025 after selling out during the quarter.
Petrus Trust Company sold 19,060 Teladoc Health shares in Q3 2025, an estimated $166K.
Petrus Trust Company first reported a position in Teladoc Health in Q2 2025 and held it in 1 quarter.
Petrus Trust Company's Teladoc Health position peaked at $166K in Q2 2025.
355 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2025.

Based on Petrus Trust Company's 13F filing for Q3 2025, filed 14 Nov 2025.